Health Care Sector Update for 06/15/2017: ADMP,SKLN,QBIO

Shutterstock photo

Top Health Care Stocks

JNJ +0.13%

PFE +0.13%

ABT +1.03%

MRK -0.35%

AMGN -0.68%

Health care stocks still were narrowly lower in a losing day for the broader U.S. markets. At last look, the NYSE Health Care Index was slipping 0.3% while shares of health care companies in the S&P 500 also were down 0.2% as a group.

In company news, Adamis Pharmaceuticals Corp ( ADMP ) soared Thursday, climbing over 53% to a new 52-week high of $5.75 a share, after federal regulators approved the company's epinephrine injection for the emergency treatment of Type 1 allergic reactions, including anaphylaxis.

The company expects a commercial launch of the new injector - which will be marketed under the Symjepi brand name - during the second half of 2017.

In other sector news,

(+) SKLN, The company's Streamway system to collect and dispose infectious fluids following surgery qualifies for a CE mark, setting the stage for a commercial launch in Europe before the end of 2017.

(-) QBIO, Signs license agreement with The Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology to develop and market a novel chemotherapeutic drug to treat liver cancer.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , US Markets
Referenced Symbols: ADMP , SKLN , QBIO

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com